Amerisource Health Services LLC recalls glipiZIDE
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications:
- Products
-
- glipiZIDE
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 2,028 units (cartons of 30 individual unit doses)
- About this recall
- glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11